Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Child Development & Parenting: Infants (0-2)
Resources
Basic Information
Infant Development: How Your Baby Grows and MaturesInfant Parenting: Keeping Your Baby Healthy and HappyInfant Safety: Keeping Your Baby SafeInfant Enrichment: Stimulating Your Baby
More InformationLatest News
Cause of Sudden Unexpected Infant Deaths Shifts in the U.S.Babies Face Higher SIDS Risk in Certain StatesNICU Family Integrated Care Ups Infant, Parent OutcomesBabies With Normal Head Size Might Still Have Zika-Linked Brain DamageZika Tied to Rise in U.S. Birth Defects: CDCNutrients in Child's First 1,000 Days Key for NeurodevelopmentOpioid Epidemic Also Taking Toll on BabiesHome Visit Program Can Help Prevent Toddler ObesityHealth Tip: Succeed in Toilet TrainingNeurodevelopment Not Impacted by Glucocorticoids in PreemiesToo Many Babies Still Die Needlessly of SIDS, CDC Says16 Percent of Infants Receive Complementary Foods Too Early2013 to 2015 Infant Mortality Rate Varied by State and RaceHealth Tip: Health Tip: Prepare Your Child for the DentistMost U.S. Babies Start Solid Foods Too SoonSpecial Baby Formula Doesn't Seem to Prevent Type 1 DiabetesHealth Tip: Ways to Bond With BabyThe Sooner Kids Learn to Eat Healthy, the BetterHealth Tip: Kids and Window BlindsChoosing Safe Toys for the HolidaysPut Safety on Your Toy Shopping ListSpoon-Feeding Not Necessarily Safer for InfantsZika Babies Facing Increasing Health Problems With AgeNearby Fracking Linked to Low Birth WeightsWindow Blinds: A Silent Killer in Your HomeHealth Tip: Starting a Tooth Brushing Routine EarlyWhen a Preemie Goes Home, Dad Stresses OutState Newborn Screening Policies Cut Infant Cardiac DeathsLock Eyes With Your Baby, Synchronize Brain Waves?Newborns in Pain Might Not Show ItHealth Tip: Childproof Your HomePractice Variation in Treatment for Bronchiolitis in InfantsHealth Tip: How to Clean a Breast PumpBabies Start Connecting Words Early OnHealth Tip: Infant Medication Advice For New MomsHow to Spot the Virus That Puts Some Babies in the HospitalProlonged Breast-Feeding May Guard Against Teen EczemaVaccination Coverage High for Children Aged 19 to 35 MonthsU.S. Preemie Birth Rates Rise 2 Years in a RowDelayed Cord Clamping Not Beneficial for Preterm InfantsEven Partial Breast-Feeding for First Few Months Lowers SIDS RiskHealth Tip: Sleep Train Your BabyACAAI: Doctors Not Adhering to New Peanut GuidelinesHypothermia May Help Newborns With EncephalopathyOb/Gyns Warn Against 'Vaginal Seeding' Trend for NewbornsKids, Don't Touch the Toys at the Doctor's OfficeCDC Updates Zika Guidance for Infant CareHigher Doses of Vitamin D May Boost Preemies' Bone HealthHealth Tip: Avoid Baby Sleep PositionersHelping Preemies Avoid Unnecessary Antibiotics
Questions and AnswersLinks
Related Topics

Child & Adolescent Development: Overview
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Early (3-7)
Child Development & Parenting: Middle (8-11)

Neurodevelopment Not Impacted by Glucocorticoids in Preemies


HealthDay News
Updated: Jan 10th 2018

new article illustration

WEDNESDAY, Jan. 10, 2018 (HealthDay News) -- Use of inhaled glucocorticoids in extremely preterm infants for the prevention of bronchopulmonary dysplasia does not lead to a higher rate of neurodevelopmental disability at 2 years, according to a study published in the Jan. 11 issue of the New England Journal of Medicine.

Dirk Bassler, M.D., from University of Zurich, and colleagues randomly assigned 863 infants (gestational age, 23 weeks 0 days to 27 weeks 6 days) to receive early (within 24 hours after birth) inhaled budesonide or placebo. A long-term composite outcome of neurodevelopmental disability among survivors included cerebral palsy, cognitive delay (a Mental Development Index score of <85 on the Bayley Scales of Infant Development, Second Edition), deafness, or blindness at a corrected age of 18 to 22 months.

Based on follow-up data from 629 infants, the researchers found that 148 of 308 infants assigned to budesonide had neurodevelopmental disability versus 165 of 321 infants assigned to placebo (relative risk, adjusted for gestational age, 0.93; 95 percent confidence interval, 0.80 to 1.09; P = 0.40). For individual components of the composite outcome there was similarly no significant differences. However, there were more deaths among infants randomized to budesonide, compared to those given placebo (relative risk, 1.37; 95 percent confidence interval, 1.01 to 1.86; P = 0.04).

"We found no effect of budesonide on the risk of neurodevelopmental disability among surviving extremely preterm infants at 18 to 22 months of age," the authors write. "However, the mortality rate was higher in the budesonide group."

The research was funded by Chiesi Farmaceutici, which provided the study drugs free of charge.

Abstract/Full Text (subscription or payment may be required)